Oncimmune Holdings (GB:ONC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oncimmune Holdings has secured three new contracts valued at £0.34 million, building on its recent commercial success of £2.14 million in contracts over the past three months. The deals with top global pharmaceutical companies highlight Oncimmune’s growing reputation and ability to secure repeat business. As the company progresses, it remains on track to meet its FY2025 revenue targets, showcasing its potential for profitability.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
